Status:
UNKNOWN
CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
IUGR
Prenatal Disorder
Eligibility:
FEMALE
18+ years
Brief Summary
According to french recommandations for IUGR management we have to propose a CGH-array analysis if the IUGR is severe (bellow the 3rd percentile) and early (in the second trimester). However there is ...
Eligibility Criteria
Inclusion
- pregnant women
- fetus with an isolated intra-uterine growth restriction (IUGR) severe (bellow the third percentile on CFEF curves) and early (between 21 and 24 gestational weeks).
Exclusion
- associated IUGR (with other abnormalities during prenatal screening)
Key Trial Info
Start Date :
January 31 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04729361
Start Date
January 31 2021
End Date
November 30 2021
Last Update
January 28 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.